Biggest News Aggregation in the World
📰 Preserved Phase News

Preserved Phase News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Preserved Phase. Real-time updates on events, politics, business and more.

CHMP issues positive opinion to expand Jardiance (empagliflozin) indication based on unprecedented benefit in adult heart failure patients with preserved ejection fraction

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has granted a positive opinion recommending Jardiance® (empagliflozin) for the treatment of adults with symptomatic chronic heart failure, Boehringer Ingelheim and Eli Lilly and Company announced today.1
Rheinland Pfalz Stephan Thalen Stefan Anker Waheed Jamal Stefanie Molkenthin Eli Lilly

Boehringer Ingelheim: CHMP issues positive opinion to expand Jardiance (empagliflozin) indication based on unprecedented benefit in adult heart failure patients with preserved ejection fraction

- The positive opinion is based on the landmark EMPEROR-Preserved Phase III trial, which showed significant outcomes in patients with heart failure with left ventricular ejection fraction over 40%1 If
Stephan Thalen Stefan Anker Waheed Jamal Stefanie Molkenthin Eli Lilly Jeff Emmick

Investegate |Olink Proteomics AB Announcements | Olink Proteomics AB: Olink participates in one of the largest proteomics studies enabling new treatment options for patients with heart failure

Investegate announcements from Olink Proteomics AB, Olink participates in one of the largest proteomics studies enabling new treatment options for patients with heart failure
United States Uppsala Lan Andrea Prander Faiez Zannad Jan Medina Exchange Commission

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science